Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + epinephrine is a combination injectable local anesthetic used to induce numbness or loss of feeling in specific areas during medical procedures. Lidocaine acts as a local anesthetic by stabilizing neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, thereby blocking pain signals. Epinephrine is added as a vasoconstrictor to slow the absorption of lidocaine into systemic circulation, which prolongs its anesthetic effect at the site of administration and reduces bleeding during procedures. This combination is commonly used for minor surgical interventions, dental procedures, skin lesion removal, biopsies, wound suturing, and other situations where localized anesthesia with reduced bleeding is desired[1][2][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + epinephrine.